In addition to the close associations of NGAL with obesity observed in previous studies, it has also been reported that NGAL plays an important role in the pathophysiology of other metabolic diseases, such as dyslipidaemia, dysglycaemia, and bone metabolic disease (18–20). This evidence concerns the gene LCN2 and obesity due to melanocortin 4 receptor deficiency.